20 Microns Ltd

- No fixed CapEx plans are finalized yet, and significant investments are still being reworked due to changing market dynamics. - The company is continuously evaluating growth opportunities and CapEx requirements, which will be shared once clarity is achieved. - Existing debt includes long-term debt, short-term debt, fixed deposits, and discounting components. - Long-term debt is small (around INR 8-10 crore) and expected to be repaid within the next few months. - No explicit mention of new fundraising through debt or equity in the near term. - The focus is on managing growth with minimal CapEx and leveraging existing capacities and contract manufacturing. - Improved financial performance and ratings may reduce interest costs further, indicating better debt management. - Overall, no concrete plans for new debt or equity fundraising were disclosed during the call.

- Currently, 20 Microns is undertaking traditional CapEx of INR 10-15 crores for machinery upgrades and additions over the next 6-12 months. - Significant CapEx plans are still under evaluation due to changing market dynamics and have not been finalized. - The company is actively working on potential high-investment projects and strategic initiatives including JVs and collaborations both in India and abroad. - A JV with German company Sievert for manufacturing construction chemicals and building products is in negotiation; clarity on CapEx and manufacturing plans expected in 6-8 weeks. - There are plans to potentially expand capacities and increase the share of the higher-margin kaolin business, but these require careful consideration due to capital intensity. - No immediate large-scale CapEx is planned; expected to manage growth for 1.5+ years with existing capacity and minimal CapEx. - Updates on finalized CapEx plans and strategic investments will be communicated when ready.

- Company targets a 15% to 18% year-on-year revenue growth over the next 3 to 5 years (Page 11, 16, 20). - Mineral fertilizers and 20 Microns construction chemicals segments expected to grow 5 times in 5 years, from INR 10 crore to approximately INR 50-250 crores in revenue (Page 17). - Current capacity utilization is around 85%, with sufficient capacity via own manufacturing, toll, and contract manufacturing to handle growth for at least 1.5 years without major CapEx (Page 12, 20). - New product additions and increasing market penetration, particularly in the Nano segment and Kaolin business, are growth drivers (Page 21, 20). - Strategic initiatives including potential JV, expansion in India and abroad, and adding mines are in progress to support growth (Page 11). - Seasonality lost post-COVID; market demand fluctuates roughly every 2-3 months (Page 12). - Minimal CapEx planned in short term (~INR 10-15 crore annually); major CapEx plans under consideration based on market dynamics (Page 16, 20).

- The company expects revenue growth of 15% to 18% for FY24 and aims to maintain this trajectory over the next 2-3 years. - EBITDA margins are targeted to remain stable around 14% to 15%, with a likely improvement of 50 to 100 basis points in the next 1-2 years. - Margins are expected to be sustainable, driven by a balanced product mix and more value-added and cutting-edge technology products. - Minimal CapEx is planned for the next few quarters to support growth without capacity bottlenecks, with major CapEx plans under evaluation due to changing market dynamics. - The mineral fertilizers and construction chemicals segments are expected to grow significantly, potentially increasing revenue from INR 10 crore to around INR 50-250 crore over 5 years. - Return ratios like ROE and ROCE are improving, with expectations for them to stabilize at higher levels over 3-4 years.

The transcript from the Q2 FY24 Earnings Conference Call for 20 Microns Limited does not explicitly mention the current or expected order book or pending orders in specific terms. However, some relevant insights include: - The company is maintaining steady demand across various product segments, balancing domestic and export markets. - JSW is an existing approved vendor with ongoing system supplies. - Grasim is an approved vendor with trial orders initiated and expected ramp-up as their new plants come online. - Market demand is described as somewhat erratic and changing, requiring continuous engagement with customers. - No specific quantitative details on order book or pending orders were disclosed during the call. Overall, while no precise order book data is provided, the company indicates active engagements with key clients and a steady flow of orders aligned with their production capacity (~85% utilized).